{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:23:14Z","timestamp":1790774594705,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.drudis.2021.12.018","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T20:24:34Z","timestamp":1640377474000},"page":"1652-1660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP\/Alsin"],"prefix":"10.1016","volume":"27","author":[{"given":"Matteo","family":"Rossi Sebastiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ermondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.drudis.2021.12.018_b0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.drudis.2021.12.018_b0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd1799","article-title":"Computer-based de novo design of drug-like molecules","volume":"4","author":"Schneider","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.drudis.2021.12.018_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acsmedchemlett.0c00581","article-title":"Steering new drug discovery campaigns: permeability, solubility, and physicochemical properties in the bRo5 chemical space","volume":"12","author":"Caron","year":"2021","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.drudis.2021.12.018_b0020","first-page":"1","article-title":"Modeling ErbB2-p130Cas interaction to design new potential anticancer agents","volume":"9","author":"Costamagna","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.drudis.2021.12.018_b0025","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1107\/S2059798317008920","article-title":"An overview of comparative modelling and resources dedicated to large-scale modelling of genome sequences","volume":"73","author":"Lam","year":"2017","journal-title":"Acta Crystallogr Sect D Struct Biol"},{"key":"10.1016\/j.drudis.2021.12.018_b0030","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1016\/j.csbj.2020.11.007","article-title":"Homology modeling in the time of collective and artificial intelligence","volume":"18","author":"Hameduh","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.drudis.2021.12.018_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cbdd.13388","article-title":"Homology modeling in drug discovery: overview, current applications, and future perspectives","volume":"93","author":"Muhammed","year":"2019","journal-title":"Chem Biol Drug Des"},{"issue":"Suppl 1","key":"10.1016\/j.drudis.2021.12.018_b0045","first-page":"345","volume":"86","author":"Kryshtafovych","year":"2019","journal-title":"HHS Public Access"},{"issue":"12","key":"10.1016\/j.drudis.2021.12.018_b0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/prot.25823","article-title":"Critical assessment of methods of protein structure prediction (CASP)\u2014round XIII","volume":"87","author":"Kryshtafovych","year":"2019","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"10.1016\/j.drudis.2021.12.018_b0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"7873","key":"10.1016\/j.drudis.2021.12.018_b0060","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"issue":"42","key":"10.1016\/j.drudis.2021.12.018_b0065","first-page":"191","article-title":"Activities at the Universal Protein Resource (UniProt)","volume":"2014","author":"UniProt Consortium","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.drudis.2021.12.018_b0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0897190020930972","article-title":"Challenges in evaluating safety and efficacy in drug development for rare diseases: a review for pharmacists","volume":"34","author":"Shah","year":"2021","journal-title":"J Pharm Pract"},{"issue":"2","key":"10.1016\/j.drudis.2021.12.018_b0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"21\u201322","key":"10.1016\/j.drudis.2021.12.018_b0080","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.drudis.2013.08.006","article-title":"Multifaceted roles of ultra-rare and rare disease patients\/parents in drug discovery","volume":"18","author":"Wood","year":"2013","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.drudis.2021.12.018_b0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/342359","article-title":"Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene","volume":"71","author":"Eymard-Pierre","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.drudis.2021.12.018_b0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12035-007-0034-x","article-title":"Alsin and the molecular pathways of amyotrophic lateral sclerosis","volume":"36","author":"Chandran","year":"2007","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.drudis.2021.12.018_b0095","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/01.WNL.0000048207.28790.25","article-title":"Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families","volume":"60","author":"Lesca","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.drudis.2021.12.018_b0100","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"10.1016\/j.drudis.2021.12.018_b0105","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/hmg\/ddg184","article-title":"ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics","volume":"12","author":"Otomo","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.drudis.2021.12.018_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.594975","article-title":"The neglected genes of ALS: cytoskeletal dynamics impact synaptic degeneration in ALS","volume":"14","author":"Castellanos-Montiel","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"44","key":"10.1016\/j.drudis.2021.12.018_b0115","doi-asserted-by":"crossref","first-page":"17135","DOI":"10.1074\/jbc.RA118.003849","article-title":"Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function","volume":"293","author":"Sato","year":"2018","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.drudis.2021.12.018_b0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2004.08.009","article-title":"Structure, exchange determinants, and family-wide Rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5","volume":"118","author":"Delprato","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.drudis.2021.12.018_b0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00894-008-0381-1","article-title":"An interrupted beta-propeller and protein disorder: structural bioinformatics insights into the N-terminus of alsin","volume":"15","author":"Soares","year":"2009","journal-title":"J Mol Model"},{"issue":"23","key":"10.1016\/j.drudis.2021.12.018_b0130","doi-asserted-by":"crossref","first-page":"24612","DOI":"10.1074\/jbc.M313504200","article-title":"Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor","volume":"279","author":"Topp","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2021.12.018_b0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2021.06.095","article-title":"The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2","volume":"569","author":"Shimakura","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.drudis.2021.12.018_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpn.2013.09.009","article-title":"Infantile-onset ascending hereditary spastic paralysis: a case report and brief literature review","volume":"18","author":"Racis","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.drudis.2021.12.018_b0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/hmg\/ddi440","article-title":"Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2\/alsin exhibit age-dependent neurological deficits and altered endosome trafficking","volume":"15","author":"Hadano","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"5\u20136","key":"10.1016\/j.drudis.2021.12.018_b0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/21678421.2012.756036","article-title":"A novel compound heterozygous ALS2 mutation in two Italian siblings with juvenile amyotrophic lateral sclerosis","volume":"14","author":"Luigetti","year":"2013","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"W1","key":"10.1016\/j.drudis.2021.12.018_b0155","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.drudis.2021.12.018_b0160","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.drudis.2021.12.018_b0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"issue":"24","key":"10.1016\/j.drudis.2021.12.018_b0170","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/bioinformatics\/btm474","article-title":"InterProSurf: a web server for predicting interacting sites on protein surfaces","volume":"23","author":"Negi","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2021.12.018_b0175","doi-asserted-by":"crossref","unstructured":"Mirdita M, Ovchinnikov S, Steinegger M. ColabFold \u2013 making protein folding accessible to all. bioRxiv. Published online August 15, 2021. https:\/\/doi.org\/10.1101\/2021.08.15.456425.","DOI":"10.1101\/2021.08.15.456425"},{"issue":"1\u20132","key":"10.1016\/j.drudis.2021.12.018_b0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: a consensus meeting","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph Lateral Scler"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621005705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621005705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:58:07Z","timestamp":1761224287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644621005705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1359644621005705"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2021.12.018","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP\/Alsin","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2021.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}